Gene-environment interactions in ocular diseases

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 667, Issue 1-2, 2009, Pages 98-117

  Sacca, S C ^a   Bolognesi, C ^a   Battistella, A ^b   Bagnis, A ^a   Izzotti, A ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Age related macular degeneration; Cataract; DNA damage; Glaucoma; Individual susceptibility; Oxidative stress

Indexed keywords

ANTIOXIDANT; CIGARETTE SMOKE; LIPOPROTEIN;

ANTERIOR EYE CHAMBER; AQUEOUS HUMOR FLOW; BLINDNESS; CATARACT; CELL LOSS; CLINICAL TRIAL; COMET ASSAY; DIET; DNA DAMAGE; ENVIRONMENTAL FACTOR; EXPERIMENTAL STUDY; EYE DISEASE; GENETIC SUSCEPTIBILITY; GENOTOXICITY; GLAUCOMA; HEREDITY; HUMAN; INTRAOCULAR HYPERTENSION; LIGHT; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OPTIC NERVE LESION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR; TISSUE DEGENERATION; TRABECULAR MESHWORK; ULTRAVIOLET RADIATION;

AGING; CATARACT; DNA DAMAGE; EYE DISEASES; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GLAUCOMA; HUMANS; MACULAR DEGENERATION; OXIDATIVE STRESS;

EID: 67649201148     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.11.002     Document Type: Review

References (261)

1. Congdon N., Vingerling J.R., Klein B.E., West S., Friedman D.S., Kempen J., O'Colmain B., Wu S.Y., and Taylor H.R. Prevalence of cataract and pseudophakia/aphakia in the United States. Arch. Ophthalmol. 122 (2004) 487-494
2. Gohdes D.M., Balamurugan A., Larsen B.A., and Maylahn C. Age-related eye diseases: an emerging challenge for public health professionals. Prev. Chronic Dis. 2 (2005) 1-6
3. Quigley H.A., and Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90 (2006) 262-267
4. Friedman D.S., O'Colmain B.J., Muñoz B., Tomany S.C., McCarty C., de Jong P.T., Nemesure B., Mitchell P., and Kempen J. Eye diseases prevalence research group, prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 122 (2004) 564-572
5. Quigley H.A. Neuronal death in glaucoma. Prog. Retin. Eye Res. 18 (1999) 39-57
6. Weber A.J., and Harman C.D. Structure-function relations of parasol cells in the normal and glaucomatous primate retina. Invest. Ophthalmol. Vis. Sci. 46 (2005) 3197-3207
7. Yücel Y.H., Zhang Q., Gupta N., Kaufman P.L., and Weinreb R.N. Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch. Ophthalmol. 118 (2000) 378-384
8. Izzotti A., Bagnis A., and Saccà S.C. The role of oxidative stress in glaucoma. Mutat. Res. 612 (2006) 105-114
9. Flammer J., Orgul S., Costa V.P., Orzalesi N., Krieglstein G.K., Serra L.M., Renard J.P., and Stefansson E. The impact of ocular blood flow in glaucoma. Prog. Retin. Eye Res. 21 (2002) 359-393
10. Kirwan R.P., Fenerty C.H., Crean J., Wordinger R.J., Clark A.F., and O'Brien C.J. Influence of cyclical mechanical strain on extracellular matrix gene expression in human lamina cribrosa cells in vitro. Mol. Vis. 11 (2005) 798-810
11. Tezel G., Yang X., Luo C., Peng Y., Sun S.L., and Sun D. Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia. Invest. Ophthalmol. Vis. Sci. 48 (2007) 705-714
12. Rönkkö S., Rekonen P., Kaarniranta K., Puustjarvi T., Teräsvirta M., and Uusitalo H. Phospholipase A2 in chamber angle of normal eyes and patients with primary open angle glaucoma and exfoliation glaucoma. Mol. Vis. 13 (2007) 408-417
13. Wilson R., and Martone J. Epidemiology of chronic angle glaucoma. In: Ritch R., Schields M., and Krupin T. (Eds). The Glaucomas. 2nd ed. (1996), Mosby, St. Louis 753-768
14. Racette L., Wilson M.R., Zangwill L.M., Weinreb R.N., and Sample P.A. Primary open-angle glaucoma in blacks: a review. Surv. Ophthalmol. 48 (2003) 295-313
15. Gong G., Kosoko-Lasaki S., Haynatzki G., Lynch H.T., Lynch J.A., and Wilson M.R. Inherited, familial and sporadic primary open-angle glaucoma. J. Natl. Med. Assoc. 99 (2007) 559-563
16. Saccà S.C., Pascotto A., Camicione P., Capris P., and Izzotti A. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch. Ophthalmol. 123 (2005) 458-463
17. Saccà S.C., Izzotti A., Rossi P., and Traverso C. Glaucomatous outflow pathway and oxidative stress. Exp. Eye Res. 84 (2007) 389-399
18. Maepea O., and Bill A. Pressures in the juxtacanalicular tissue and Schlemm's canal in monkeys. Exp. Eye Res. 65 (1992) 879-883
19. Alvarado J.A., Alvarado R.G., Yeh R.F., Franse-Carman L., Marcellino G.R., and Brownstein M.J. A new insight into the cellular regulation of aqueous outflow: how trabecular meshwork endothelial cells drive a mechanism that regulates the permeability of Schlemm's canal endothelial cells. Br. J. Ophthalmol. 89 (2005) 1500-1505
20. Alvarado J.A., Murphy C.G., Polansky J.R., and Juster R. Age related changes in trabecular meshwork cellularity. Invest. Ophthalmol. Vis. Sci. 21 (1981) 714-727
21. Allingham R.R., de Kater A.W., Ethier C.R., Anderson P.J., Hertzmark E., and Epstein D.L. The relationship between pore density and outflow facility in human eyes. Invest. Ophthalmol. Vis. Sci. 33 (1992) 1661-1669
22. Sit A.J., Coloma F.M., Ethier C.R., and Johnson M. Factors affecting the pores of the inner wall endothelium of Schlemm's canal. Invest. Ophthalmol. Vis. Sci. 38 (1997) 1517-1525
23. Johnson M., Chan D., Read A.T., Christensen C., Sit A., and Ethier C.R. The pore density in the inner wall endothelium of Schlemm's canal of glaucomatous eyes. Invest. Ophthalmol. Vis. Sci. 43 (2002) 2950-2955
24. Johnstone M.A. The aqueous outflow system as a mechanical pump: evidence from examination of tissue and aqueous movement in human and non-human primates. J. Glaucoma 13 (2004) 421-438
25. Johnson M. What controls aqueous humour outflow resistance?. Exp. Eye Res. 82 (2006) 545-557
26. Alvarado J.A., Yeh R.F., Franse-Carman L., Marcellino G., and Brownstein M.J. Interactions between endothelia of the trabecular meshwork and of Schlemm's canal: a new insight into the regulation of aqueous outflow in the eye. Trans. Am. Ophthalmol. Soc. 103 (2005) 148-162
27. Alvarado J.A., Betanzos A., Franse-Carman L., Chen J., and González-Mariscal L. Endothelia of Schlemm's canal and trabecular meshwork: distinct molecular, functional, and anatomic features. Am. J. Physiol. Cell Physiol. 286 (2004) C621-C634
28. Grierson I., and Howes R.C. Age-related depletion of the cell population in the human trabecular meshwork. Eye 1 (1987) 204-210
29. Gabelt B.T., Gottanka J., Lütjen-Drecoll E., and Kaufman P.L. Aqueous humor dynamics and trabecular meshwork and anterior ciliary muscle morphologic changes with age in rhesus monkeys. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2118-2125
30. Gabelt B.T., and Kaufman P.L. Changes in aqueous humor dynamics with age and glaucoma. Prog. Retin. Eye Res. 24 (2005) 612-637
31. Wentz-Hunter K., Kubota R., Shen X., and Yue B.Y. Extracellular myocilin affects activity of human trabecular meshwork cells. J. Cell. Physiol. 200 (2004) 45-52
32. Mitchell C.H., Fleischhauer J.C., Stamer W.D., Peterson-Yantorno K., and Civan M.M. Human trabecular meshwork cell volume regulation. Am. J. Physiol. Cell Physiol. 283 (2002) C315-C326
33. Soto D., Comes N., Ferrer E., Morales M., Escalada A., Pales J., Solsona C., Gual A., and Gasull X. Modulation of aqueous humor outflow by ionic mechanisms involved in trabecular meshwork cell volume regulation. Invest. Ophthalmol. Vis. Sci. 45 (2004) 3650-3661
34. Okada Y., Maeno E., Shimizu T., Dezaki K., Wang J., and Morishima S. Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J. Physiol. 532 (2001) 3-16
35. Minamino T., Miyauchi H., Yoshida T., Ishida Y., Yoshida H., and Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105 (2002) 1541-1544
36. Chow J., Liton P.B., Luna C., Wong F., and Gonzalez P. Effect of cellular senescence on the P2Y-receptor mediated calcium response in trabecular meshwork cells. Mol. Vis. 13 (2007) 1926-1933
37. Izzotti A., Saccà S.C., Di Marco B., Penco S., and Bassi A.M. Antioxidant activity of timolol on endothelial cells and its relevance for glaucoma course. Eye 2 (2007) 1-9
38. Voghel G., Thorin-Trescases N., Farhat N., Nguyen A., Villeneuve L., Mamarbachi A.M., Fortier A., Perrault L.P., Carrier M., and Thorin E. Cellular senescence in endothelial cells from atherosclerotic patients is accelerated by oxidative stress associated with cardiovascular risk factors. Mech. Ageing Dev. 128 (2007) 662-671
39. Babizhayev M.A., and Bunin A.Y. Lipid peroxidation in open angle glaucoma. Acta Ophthalmol. 67 (1989) 371-377
40. Green K. Free radicals and aging of anterior segment tissues of the eye: a hypothesis. Ophthal. Res. 27 (1995) 143-149
41. Alvarado J., Murphy C., Polansky J., and Juster R. Studies on pathogenesis of primary open angle glaucoma: regional analyses of trabecular meshwork cellularity and dense collagen. In: Ticho U., and David R. (Eds). Recent Advances in Glaucoma (1984), Elsevier, Amsterdam 3-8
42. Alvarado J.A., Murphy C., and Juster R. Trabecular meshwork cellularity in primary open-angle glaucoma and non glaucomatous normals. Ophthalmology 91 (1984) 564-579
43. Kahn M.G., Giblin F.J., and Epstein D.L. Glutathione in calf trabecular meshwork and its relation to aqueous humor outflow facility. Invest. Ophthalmol. Vis. Sci. 24 (1983) 1283-1287
44. Caballero M., Liton P.B., Epstein D.L., and Gonzalez P. Proteasome inhibition by chronic oxidative stress in human trabecular meshwork cells. Biochem. Biophys. Res. Commun. 308 (2003) 346-352
45. De La Paz M.A., and Epstein D.L. Effect of age on superoxide dismutase activity of human trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1849-1853
46. Pompella A., Visvikis A., Paolicchi A., De Tata V., and Casini A.F. The changing faces of glutathione, a cellular protagonist. Biochem. Pharmacol. 66 (2003) 1499-1503
47. Erden-Inal M., Sunal E., and Kanbak G. Age-related changes in the glutathione redox system. Cell Biochem. Funct. 20 (2002) 61-66
48. Gherghel D., Griffiths H.R., Hilton E.J., Cunliffe I.A., and Hosking S.L. Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 46 (2005) 877-883
49. Hogg P., Calthorpe M., Batterbury M., and Grierson I. Aqueous humor stimulates the migration of human trabecular meshwork cells in vitro. Invest. Ophthalmol. Vis. Sci. 41 (2000) 1091-1098
50. Li G., Luna C., Liton P.B., Navarro I., Epstein D.L., and Gonzalez P. Sustained stress response after oxidative stress in trabecular meshwork cells. Mol. Vis. 13 (2007) 2282-2288
51. Wang N., Chintala S.K., Fini M.E., and Schuman J.S. Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype. Nat. Med. 7 (2001) 304-309
52. Li W.G., Miller Jr. F.J., Zhang H.J., Spitz D.R., Oberley L.W., and Weintraub N.L. H(2)O(2)-induced O(2) production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J. Biol. Chem. 276 (2001) 29251-29256
53. Liu Q., Ju W.K., Crowston J.G., Xie F., Perry G., Smith M.A., Lindsey J.D., and Weinreb R.N. Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage. Invest. Ophthalmol. Vis. Sci. 48 (2007) 4580-4589
54. Chen Y.N., Yamada H., Mao W., Matsuyama S., Aihara M., and Araie M. Hypoxia-induced retinal ganglion cell death and the neuroprotective effects of beta-adrenergic antagonists. Brain Res. 1148 (2007) 28-37
55. Nucci C., Tartaglione R., Cerulli A., Mancino R., Spanò A., Cavaliere F., Rombolà L., Bagetta G., Corasaniti M.T., and Morrone L.A. Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat. Int. Rev. Neurobiol. 82 (2007) 397-406
56. Toda N., and Nakanishi-Toda M. Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy. Prog. Retin. Eye Res. 26 (2007) 205-238
57. Izzotti A., Saccà S.C., Cartiglia C., and De Flora S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am. J. Med. 114 8 (2003) 638-646
58. Wolfs R.C., Klaver C.C., Ramrattan R.S., van Duijn C.M., Hofman A., and de Jong P.T. Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch. Ophthalmol. 116 (1998) 1640-1645
59. McNaught A.I., Allen J.G., Healey D.L., McCartney P.J., Coote M.A., Wong T.L., Craig J.E., Green C.M., Rait J.L., and Mackey D.A. Accuracy and implications of a reported family history of glaucoma: experience from the Glaucoma Inheritance Study in Tasmania. Arch. Ophthalmol. 118 (2000) 900-904
60. Wu S.Y., Leske M.C., and The Barbados Eye Studies Group. Associations with intraocular pressure in the Barbados Eye Study. Arch. Ophthalmol. 115 (1997) 1572-1576
61. Tielsch J.M., Sommer A., Katz J., Royall R.M., Quigley H.A., and Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 266 (1991) 369-374
62. Leske M.C., Connell A.M., Wu S.Y., Hyman L., and Schachat A.P. Distribution of intraocular pressure. The Barbados Eye Study. Arch. Ophthalmol. 115 (1997) 1051-1057
63. Klein B.E., Klein R., and Linton K.L. Intraocular pressure in an American community: the Beaver Dam Eye Study. Invest. Ophthalmol. Vis. Sci. 33 (1992) 2224-2228
64. Weih L.M., Mukesh B.N., McCarty C.A., and Taylor H.R. Association of demographic, familial, medical, and ocular factors with intraocular pressure. Arch. Ophthalmol. 119 (2001) 875-880
65. Leske M.C., Heijl A., Hussein M., Bengtsson B., Hyman L., Komaroff E., and Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch. Ophthalmol. 121 (2003) 48-56
66. Gordon M.O., Beiser J.A., Brandt J.D., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., Miller J.P., Parrish R.K., Wilson M.R., and Kass M.A. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch. Ophthalmol. 120 (2002) 714-720
67. Miglior S., Pfeiffer N., Torri V., Zeyen T., Cunha-Vaz J., Adamsons I., and European Glaucoma Prevention Study (EGPS) Group. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 114 (2007) 3-9
68. Bengtsson B. The prevalence of glaucoma. Br. J. Ophthalmol. 65 (1981) 46-49
69. Saccà S.C., Rolando M., Marletta A., Macrí A., Cerqueti P., and Ciurlo G. Fluctuations of intraocular pressure during the day in open-angle glaucoma, normal-tension glaucoma and normal subjects. Ophthalmologica 212 (1998) 115-119
70. Hong S., Seong G.J., and Hong Y.J. Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure. Arch. Ophthalmol. 125 (2007) 1010-1013
71. Jones C.A., Huberman E., Cunningham M.L., and Peak M.J. Mutagenesis and cytotoxicity in human epithelial cells by far- and near-ultraviolet radiations: action spectra. Radiat. Res. 110 (1987) 244-254
72. Godley B.F., Shamsi F.A., Liang F.Q., Jarrett S.G., Davies S., and Boulton M. Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. J. Biol. Chem. 280 (2005) 21061-21066
73. 2 in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 6255-6260
74. Zhou L., Li Y., and Yue B.Y. Oxidative stress affects cytoskeletal structure and cell-matrix interactions in cells from an ocular tissue: the trabecular meshwork. J. Cell. Physiol. 180 (1999) 182-189
75. Townsend D.M., Tew K.D., and Tapiero H. The importance of glutathione in human disease. Biomed. Pharmacother. 57 (2003) 145-155
76. Meister A. Metabolism and function of glutathione. In: Dolphin D., Poulson R., and Avramovic O. (Eds). Glutathione: Chemical, Biochemical and Medical Aspects (1989), Wiley, New York 361-374
77. Mozaffarieh M., Schoetzau A., Grieshaber M., Orgül S., Golubnitschaja O., and Flammer J. Comet assay analysis of single-stranded DNA breaks in circulating leukocytes of glaucoma patients. Mol. Vis. 14 (2008) 1584-1588
78. Lichter P.R. Genetics of the glaucomas. J. Glaucoma 10 (2001) S13-S15
79. Seidegard J., Vorachek W.R., Pero R.W., and Pearson W.R. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 7293-7297
80. Yildirim O., Ates N.A., Tamer L., Oz O., Yilmaz A., Atik U., and Camdeviren H. May glutathione S-transferase M1 positive genotype afford protection against primary open angle glaucoma?. Graefes Arch. Clin. Exp. Ophthalmol. 243 (2005) 327-333
81. Abu-Amero K.K., Al-Boudari O.M., Mohamed G.H., and Dzimiri N. T null and M null genotypes of the glutathione S-transferase gene are risk factor for CAD independent of smoking. BMC Med. Genet. 7 (2006) 38
82. Habdous M., Siest G., Herbeth B., Vincent-Viry M., and Visvikis S. Glutathione S-transferases genetic polymorphisms and human diseases: overview of epidemiological studies. Ann. Biol. Clin. 62 (2004) 15-24
83. Sekine Y., Hommura S., and Harada S. Frequency of glutathione-S-transferase 1 gene deletion and its possible correlation with cataract formation. Exp. Eye Res. 60 (1995) 159-163
84. Oz O., Aras Ates N., Tamer L., Yildirim O., and Adiguzel U. Glutathione S-transferase M1, T1, and P1 gene polymorphism in exudative age-related macular degeneration: a preliminary report. Eur. J. Ophthalmol. 16 (2006) 105-110
85. Hayes J.D., Flanagan J.U., and Jowsey I.R. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 51-88
86. Juronen E., Tasa G., Veromann S., Parts L., Tiidla A., Pulges R., Panov A., Soovere L., Koka K., and Mikelsaar A.V. Polymorphic glutathione S-transferase M1 is a risk factor of primary open-angle glaucoma among Estonians. Exp. Eye Res. 71 (2000) 447-452
87. Unal M., Güven M., Devranoǧlu K., Ozaydin A., Batar B., Tamçelik N., Görgün E.E., Uçar D., and Sarici A. Glutathione S transferase M1 and T1 genetic polymorphisms are related to the risk of primary open-angle glaucoma: a study in a Turkish population. Br. J. Ophthalmol. 91 (2007) 527-530
88. Abu-Amero K.K., Morales J., Mohamed G.H., Osman M.N., and Bosley T.M. Glutathione S-transferase M1 and T1 polymorphisms in Arab glaucoma patients. Mol. Vis. 14 (2008) 425-430
89. Fingert J.H., Héon E., Liebmann J.M., Yamamoto T., Craig J.E., Rait J., Kawase K., Hoh S.T., Buys Y.M., Dickinson J., Hockey R.R., Williams-Lyn D., Trope G., Kitazawa Y., Ritch R., Mackey D.A., Alward W.L., Sheffield V.C., and Stone E.M. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum. Mol. Genet. 8 (1999) 899-905
90. Craig J.E., and Mackey D.A. Glaucoma genetics: where are we? Where will we go?. Curr. Opin. Ophthalmol. 10 (1999) 126-134
91. Fingert J.H., Ying L., Swiderski R.E., Nystuen A.M., Arbour N.C., Alward W.L., Sheffield V.C., and Stone E.M. Characterization and comparison of the human and mouse GLC1A glaucoma genes. Genome Res. 8 (1998) 377-384
92. Kubota R., Kudoh J., Mashima Y., Asakawa S., Minoshima S., Hejtmancik J.F., Oguchi Y., and Shimizu N. Genomic organization of the human myocilin gene (MYOC) responsible for primary open angle glaucoma (GLC1A). Biochem. Biophys. Res. Commun. 242 (1998) 396-400
93. Adam M.F., Belmouden A., Binisti P., Brézin A.P., Valtot F., Béchetoille A., Dascotte J.C., Copin B., Gomez L., Chaventré A., Bach J.F., and Garchon H.J. Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Hum. Mol. Genet. 6 (1997) 2091-2097
94. Ueda J., Wentz-Hunter K.K., Cheng E.L., Fukuchi T., Abe H., and Yue B.Y. Ultrastructural localization of myocilin in human trabecular meshwork cells and tissues. J. Histochem. Cytochem. 48 (2000) 1321-1330
95. O'Brien E.T., Ren X., and Wang Y. Localization of myocilin to the golgi apparatus in Schlemm's canal cells. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3842-3849
96. Fingert J.H., Stone E.M., Sheffield V.C., and Alward W.L. Myocilin glaucoma. Surv. Ophthalmol. 47 (2002) 547-561
97. Liu Y., and Vollrath D. Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma. Hum. Mol. Genet. 13 11 (2004) 1193-1204
98. Yam G.H., Gaplovska-Kysela K., Zuber C., and Roth J. Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis. Invest. Ophthalmol. Vis. Sci. 48 4 (2007) 1683-1690
99. Alward W.L., Fingert J.H., Coote M.A., Johnson A.T., Lerner S.F., Junqua D., Durcan F.J., McCartney P.J., Mackey D.A., Sheffield V.C., and Stone E.M. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N. Engl. J. Med. 338 (1998) 1022-1027
100. Bruttini M., Longo I., Frezzotti P., Ciappetta R., Randazzo A., Orzalesi N., Fumagalli E., Caporossi A., Frezzotti R., and Renieri A. Mutations in the myocilin gene in families with primary open-angle glaucoma and juvenile open-angle glaucoma. Arch. Ophthalmol. 121 (2003) 1034-1038
101. Shimizu S., Lichter P.R., Johnson A.T., Zhou Z., Higashi M., Gottfredsdottir M., Othman M., Moroi S.E., Rozsa F.W., Schertzer R.M., Clarke M.S., Schwartz A.L., Downs C.A., Vollrath D., and Richards J.E. Age-dependent prevalence of mutations at the GLC1A locus in primary open-angle glaucoma. Am. J. Ophthalmol. 130 (2000) 165-177
102. Rezaie T., Child A., Hitchings R., Brice G., Miller L., Coca-Prados M., Heon E., Krupin T., Ritch R., Kreutzer D., Crick R.P., and Sarfarazi M. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295 (2002) 1077-1079
103. Kumar A., Basavaraj M.G., Gupta S.K., Qamar I., Ali A.M., Bajaj V., Ramesh T.K., Prakash D.R., Shetty J.S., and Dorairaj S.K. Role of CYP1B1, MYOC, OPTN, and OPTC genes in adult-onset primary open-angle glaucoma: predominance of CYP1B1 mutations in Indian patients. Mol. Vis. 13 (2007) 667-676
104. Park B.C., Tibudan M., Samaraweera M., Shen X., and Yue B.Y. Interaction between two glaucoma genes, optineurin and myocilin. Genes Cells 12 (2007) 969-979
105. Sarfarazi M., and Rezaie T. Optineurin in primary open angle glaucoma. Ophthalmol. Clin. North Am. 16 (2003) 529-541
106. Wiggs J.L. Genetic etiologies of glaucoma. Arch. Ophthalmol. 125 (2007) 30-37
107. La Rosa F.A., Gross R.L., and Orengo-Nania S. Central corneal thickness of Caucasians and African Americans in glaucomatous and nonglaucomatous populations. Arch. Ophthalmol. 119 (2001) 23-27
108. Singh R.P., Goldberg I., Graham S.L., Sharma A., and Mohsin M. Central corneal thickness, tonometry, and ocular dimensions in glaucoma and ocular hypertension. J. Glaucoma 10 (2001) 206-210
109. Ventura A.C., Böhnke M., and Mojon D.S. Central corneal thickness measurements in patients with normal tension glaucoma, primary open angle glaucoma, pseudoexfoliation glaucoma, or ocular hypertension. Br. J. Ophthalmol. 85 (2001) 792-795
110. Leske M.C., Warheit-Roberts L., and Wu S.Y. Open-angle glaucoma and ocular hypertension: the Long Island Glaucoma case-control Study. Ophthal. Epidemiol. 3 (1996) 85-96
111. Mitchell P., Lee A.J., Rochtchina E., and Wang J.J. Open-angle glaucoma and systemic hypertension: the blue mountains eye study. J. Glaucoma 13 (2004) 319-326
112. Galambos P., Vafiadis J., Vilchez S.E., Wagenfeld L., Matthiessen E.T., Richard G., Klemm M., and Zeitz O. Compromised autoregulatory control of ocular hemodynamics in glaucoma patients after postural change. Ophthalmology 113 (2006) 1832-1836
113. Zeitz O., Wagenfeld L., Wirtz N., Galambos P., Matthiesen N., Wiermann A., Richard G., and Klemm M. Influence of oxygen free radicals on the tone of ciliary arteries: a model of vasospasms of ocular vasculature. Graefes Arch. Clin. Exp. Ophthalmol. 245 (2007) 1327-1333
114. Mozaffarieh M., Grieshaber M.C., and Flammer J. Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol. Vis. 14 (2008) 224-233
115. Gherghel D., Orgul S., Dubler B., Lubeck P., Gugleta K., and Flammer J. Is vascular regulation in the central retinal artery altered in persons with vasospasm?. Arch. Ophthalmol. 117 (1999) 1359-1362
116. Gherghel D., Orgul S., Gugleta K., Gekkieva M., and Flammer J. Relationship between ocular perfusion pressure and retrobulbar blood flow in patients with glaucoma with progressive damage. Am. J. Ophthalmol. 130 (2000) 597-605
117. Solberg Y., Rosner M., and Belkin M. The association between cigarette smoking and ocular diseases. Surv. Ophthalmol. 42 (1998) 535-547
118. Mehra K.S., Roy P.N., and Khare B.B. Tobacco smoking and glaucoma. Ann. Ophthalmol. 8 (1976) 462-464
119. Wilson M.R., Hertzmark E., Walker A.M., Childs-Shaw K., and Epstein D.L. A case-control study of risk factors in open-angle glaucoma. Arch. Ophthalmol. 105 (1987) 1066-1071
120. Leske M.C., Connell A.M., Wu S.Y., Hyman L.G., and Schachat A.P. Risk factors for open-angle glaucoma. The Barbados eye study. Arch. Ophthalmol. 113 (1995) 918-924
121. Klein B.E., Klein R., and Ritter L.L. Relationship of drinking alcohol and smoking to prevalence of open-angle glaucoma. The Beaver Dam eye study. Ophthalmology 100 (1993) 1609-1613
122. Cakir Y., Yang Z., Knight C.A., Pompilius M., Westbrook D., Bailey S.M., Pinkerton K.E., and Ballinger S.W. Effect of alcohol and tobacco smoke on mtDNA damage and atherogenesis. Free Radic. Biol. Med. 43 (2007) 1279-1288
123. McLeod D.S., Taomoto M., Otsuji T., Green W.R., Sunness J.S., and Lutty G.A. Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1986-1993
124. Rodrigues E.B. Inflammation in dry age-related macular degeneration. Ophthalmologica 221 (2007) 143-152
125. Beatty S., Koh H., Phil M., Henson D., and Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 45 (2000) 115-134
126. Imamura Y., Noda S., Hashizume K., Shinoda K., Yamaguchi M., Uchiyama S., Shimizu T., Mizushima Y., Shirasawa T., and Tsubota K. Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 11282-11287
127. Cai J., Nelson K.C., Wu M., Sternberg Jr. P., and Jones D.P. Oxidative damage and protection of the RPE. Prog. Retin. Eye Res. 19 (2000) 205-221
128. Hogg R.E., Woodside J.V., Gilchrist S.E., Graydon R., Fletcher A.E., Chan W., Knox A., Cartmill B., and Chakravarthy U. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology 115 (2008) 1046-1052
129. Haddad S., Chen C.A., Santangelo S.L., and Seddon J.M. The genetics of age-related macular degeneration: a review of progress to date. Surv. Ophthalmol. 51 4 (2006) 316-363
130. Zarbin M.A. Current concepts in the pathogenesis of age-related macular degeneration. Arch. Ophthalmol. 122 (2004) 598-614
131. Johnson L.V., Ozaki S., Staples M.K., Erickson P.A., and Anderson D.H. A potential role for immune complex pathogenesis in drusen formation. Exp. Eye Res. 70 (2000) 441-449
132. Tong J.P., and Yao Y.F. Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions. Clin. Biochem. 39 (2006) 267-276
133. Bora P.S., Sohn J.H., Cruz J.M., Jha P., Nishihori H., Wang Y., Kaliappan S., Kaplan H.J., and Bora N.S. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J. Immunol. 174 (2005) 491-497
134. Esfandiary H., Chakravarthy U., Patterson C., Young I., and Hughes A.E. Association study of detoxification genes in age related macular degeneration. Br. J. Ophthalmol. 89 (2005) 470-474
135. Swaroop A., Branham K.E., Chen W., and Abecasis G. Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. Hum. Mol. Genet. 16 (2007) 174-182
136. Yates J.R., and Moore A.T. Genetic susceptibility to age related macular degeneration. J. Med. Genet. 37 (2000) 83-87
137. Shibuya E., Meguro A., Ota M., Kashiwagi K., Ma buchi F., Iijima H., Kawase K., Yamamoto T., Nakamura M., Negi A., Sagara T., Nishida T., Inatani M., Tanihara H., Aihara M., Araie M., Fukuchi T., Abe H., Higashide T., Sugiyama K., Kiuchi Y., Iwase A., Kanamoto T., Ohno S., Inoko H., and Mizuki N. Association of toll-like receptor 4 gene polymorphisms with normal tension glaucoma. Invest. Ophthalmol. Vis. Sci (2008) (Epub ahead of print)
138. de Voogd S., Wolf R.C., Jansonius N.M., Uitterlinden A.G., Pols H., Hofman A., and Jong P.T. Estrogen receptors alpha and beta and the risk of open-angle glaucoma: the Rotterdam Study. Ach. Opthalmol. 1 (2008) 110-114
139. Janter J.A., Olson L.M., Spencer K., Schnetz-Boutaud N., Anderson B., Hauser M.A., Schmidt S., Postel E.A., Agarwal A., Pericak-Vance M.A., Sternberg P., and Haines J.L. Mitochondrial DNA polymorphism A4917G is independently associated with agerelated macular degeneration. PLoS ONE 3 (2008) 2091
140. Wang C.Y., Shen Y.C., Su C.H., Lo F.Y., Lee S.H., Tsai H.Y., and Fan S.S. Investigation of the association between interleukin-1beta polymorphism and normal tension glaucoma. Mol. Vis. 14 (2007) 19-23
141. Aragon-Martin J.A., Ritch R., Liebmann J., O'Brien L., Blaaow K., Mercieca F., Spiteri A., Cobb C.J., Damji K.F., Tarkkanen A., Rezaie T., Child A.H., and Sarfarazi M. Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma. Mol. Vis. 14 (2008) 533-541
142. Pasutto F., Mardin C.Y., Michels-Rautenstrauss K., Sticht H., Chavarria-Soley G., Kruse F., and Reis A. Profiling of WDR36 missense variants in German patients with glaucoma. Invest. Ophthalmol. Vis. Sci. 49 (2008) 270-274
143. Scholl H.P., Fleckenstein M., Charbel Issa P., Keilhauer C., Holz F.G., and Weber B.H. An update on the genetics of age-related macular degeneration. Mol. Vis. 13 (2007) 196-205
144. Klaver C.C., Wolfs R.C., Assink J.J., van Duijn C.M., Hofman A., and de Jong P.T. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch. Ophthalmol. 116 (1998) 1646-1651
145. Melrose M.A., Magargal L.E., and Lucier A.C. Identical twins with subretinal neovascularization complicating senile macular degeneration. Ophthal. Surg. 16 (1985) 648-651
146. Gottfredsdottir M.S., Sverrisson T., Musch D.C., and Stefánsson E. Age related macular degeneration in monozygotic twins and their spouses in Iceland. Acta Ophthalmol. Scand. 77 (1999) 422-425
147. Seddon J.M., Cote J., Page W.F., Aggen S.H., and Neale M.C. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch. Ophthalmol. 123 (2005) 321-327
148. Hammond C.J., Webster A.R., Snieder H., Bird A.C., Gilbert C.E., and Spector T.D. Genetic influence on early age-related maculopathy: a twin study. Ophthalmology 109 (2002) 730-736
149. Klein R., Meuer S.M., Moss S.E., and Klein B.E. Detection of drusen and early signs of age-related maculopathy using a nonmydriatic camera and a standard fundus camera. Ophthalmology 99 (1992) 1686-1692
150. Hyman L., and Neborsky R. Risk factors for age-related macular degeneration: an update. Curr. Opin. Ophthalmol. 13 (2002) 171-175
151. The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol. 110 (1992) 1701-1708
152. Cruickshanks K.J., Hamman R.F., Klein R., Nondahl D.M., and Shetterly S.M. The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy. Arch. Ophthalmol. 115 (1997) 242-250
153. Sommer A., Tielsch J.M., Katz J., Quigley H.A., Gottsch J.D., Javitt J.C., Martone J.F., Royall R.M., Witt K.A., and Ezrine S. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N. Engl. J. Med. 325 (1991) 1412-1417
154. Clemons T.E., Milton R.C., Klein R., Seddon J.M., Ferris F.L., and Age-Related Eye Disease Study Research Group. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS). Ophthalmology 112 (2005) 533-539
155. Li Y., Xu L., Jonas J.B., Yang H., Ma Y., and Li J. Prevalence of age-related maculopathy in the adult population in China: the Beijing eye study. Am. J. Ophthalmol. 142 (2006) 788-793
156. Oshima Y., Ishibashi T., Murata T., Tahara Y., Kiyohara Y., and Kubota T. Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br. J. Ophthalmol. 85 (2001) 1153-1157
157. Gupta S.K., Murthy G.V., Morrison N., Price G.M., Dherani M., John N., Fletcher A.E., and Chakravarthy U. Prevalence of early and late age-related macular degeneration in a rural population in northern India: the INDEYE feasibility study. Invest. Ophthalmol. Vis. Sci. 48 (2007) 1007-1011
158. Seddon J.M., Cote J., and Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch. Ophthalmol. 121 (2003) 1728-1737
159. Chiu C.J., Milton R.C., Gensler G., and Taylor A. Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the Age-Related Eye Disease Study. Am. J. Clin. Nutr. 86 (2007) 180-188
160. Chiu C.J., Milton R.C., Klein R., Gensler G., and Taylor A. Dietary carbohydrate and the progression of age-related macular degeneration: a prospective study from the Age-Related Eye Disease Study. Am. J. Clin. Nutr. 86 (2007) 1210-1218
161. Seddon J.M., Cote J., Davis N., and Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch. Ophthalmol. 121 (2003) 785-792
162. Seddon J.M., Francis P.J., George S., Schultz D.W., Rosner B., and Klein M.L. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 297 (2007) 2585
163. Nolan J., O'Donovan O., Kavanagh H., Stack J., Harrison M., Muldoon A., Mellerio J., and Beatty S. Macular pigment and percentage of body fat. Invest. Ophthalmol. Vis. Sci. 45 (2004) 3940-3950
164. Francis P.J., George S., Schultz D.W., Rosner B., Hamon S., Ott J., Weleber R.G., Klein M.L., and Seddon J.M. The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum. Hered. 63 (2007) 212-218
165. Seddon J.M., George S., Rosner B., and Klein M.L. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum. Hered. 61 (2006) 157-165
166. Knudtson M.D., Klein R., and Klein B.E. Physical activity and the 15-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Br. J. Ophthalmol. 90 (2006) 1461-1463
167. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol. 119 (2001) 1417-1436
168. Seddon J.M., Ajani U.A., Sperduto R.D., Hiller R., Blair N., Burton T.C., Farber M.D., Gragoudas E.S., Haller J., Miller D.T., and Eye Disease Case-Control Study Group. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 272 (1994) 1413-1420
169. SanGiovanni J.P., Chew E.Y., Clemons T.E., Davis M.D., Ferris F.L., Gensler G.R., Kurinij N., Lindblad A.S., Milton R.C., Seddon J.M., Sperduto R.D., and Age-Related Eye Disease Study Research Group. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch. Ophthalmol. 125 (2007) 671-679
170. Seddon J.M., Rosner B., Sperduto R.D., Yannuzzi L., Haller J.A., Blair N.P., and Willett W. Dietary fat and risk for advanced age-related macular degeneration. Arch. Ophthalmol. 119 (2001) 1191-1199
171. Tan J.S., Mitchell P., Smith W., and Wang J.J. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 114 (2007) 1143-1150
172. Klein R., Klein B.E., and Jensen S.C. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104 (1997) 1804-1812
173. Smith W., Mitchell P., Leeder S.R., and Wang J.J. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch. Ophthalmol. 116 (1998) 583-587
174. Van Leeuwen R., Klaver C.C., Vingerling J.R., Hofman A., van Duijn C.M., Stricker B.H., and de Jong P.T. Cholesterol and age-related macular degeneration: is there a link?. Am. J. Ophthalmol. 137 (2004) 750-752
175. Patel M., and Chan C.C. Immunopathological aspects of age-related macular degeneration. Semin. Immunopathol. 30 (2008) 97-110
176. Klaver C.C., Kliffen M., van Duijn C.M., Hofman A., and Cruts M. Genetic association of apolipoprotein E with age-related macular degeneration. Am. J. Hum. Genet. 63 (1998) 200-206
177. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
178. Schmidt S., Haines J.L., Postel E.A., Agarwal A., Kwan S.Y., Gilbert J.R., Pericak-Vance M.A., and Scott W.K. Joint effects of smoking history and APOE genotypes in age-related macular degeneration. Mol. Vis. 11 (2005) 941-949
179. Anderson D.H., Ozaki S., Nealon M., Neitz J., Mullins R.F., Hageman G.S., and Johnson L.V. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am. J. Ophthalmol. 131 (2001) 767-781
180. Fisher S.A., Abecasis G.R., Yashar B.M., Zareparsi S., Swaroop A., Iyengar S.K., Klein B.E., Klein R., Lee K.E., Majewski J., Schultz D.W., Klein M.L., Seddon J.M., Santangelo S.L., Weeks D.E., Conley Y.P., Mah T.S., Schmidt S., Haines J.L., Pericak-Vance M.A., Gorin M.B., Schulz H.L., Pardi F., Lewis C.M., and Weber B.H. Meta-analysis of genome scans of age-related macular degeneration. Hum. Mol. Genet. 14 (2005) 2257-2264
181. Baird P.N., Guida E., Chu D.T., Vu H.T., and Guymer R.H. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 45 (2004) 1311-1315
182. Schultz D.W., Klein M.L., Humpert A., Majewski J., and Schain M. Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. Arch. Ophthalmol. 121 (2003) 679-683
183. Curcio C.A., Millican C.L., Bailey T., and Kruth H.S. Accumulation of cholesterol with age in human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 42 (2001) 265-274
184. Yamada Y., Tian J., Yang Y., Cutler R.G., Wu T., Telljohann R.S., Mattson M.P., and Handa J.T. Oxidized low density lipoproteins induce a pathologic response by retinal pigmented epithelial cells. J. Neurochem. 105 (2008) 1187-1197
185. Tan J.S., Mitchell P., Kifley A., Flood V., Smith W., and Wang J.J. Smoking and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Arch. Ophthalmol. 125 (2007) 1089-1095
186. Seddon J.M., Willett W.C., Speizer F.E., and Hankinson S.E. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 276 (1996) 1141-1146
187. Tomany S.C., Wang J.J., Van Leeuwen R., Klein R., Mitchell P., Vingerling J.R., Klein B.E., Smith W., and De Jong P.T. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 111 (2004) 1280-1287
188. Chakravarthy U., Augood C., Bentham G.C., de Jong P.T., Rahu M., Seland J., Soubrane G., Tomazzoli L., Topouzis F., Vingerling J.R., Vioque J., Young I.S., and Fletcher A.E. Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology 114 (2007) 1157-1163
189. Khan J.C., Thurlby D.A., Shahid H., Clayton D.G., Yates J.R., Bradley M., Moore A.T., Bird A.C., and Genetic Factors in AMD Study. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br. J. Ophthalmol. 90 (2006) 75-80
190. Solberg Y., Rosner M., and Belkin M. The association between cigarette smoking and ocular diseases. Surv. Ophthalmol. 42 (1998) 535
191. Hughes A.E., Orr N., Patterson C., Esfandiary H., Hogg R., McConnell V., Silvestri G., and Chakravarthy U. Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. PLoS Med. 4 (2007) e355
192. Scott W.K., Schmidt S., Hauser M.A., Gallins P., Schnetz-Boutaud N., Spencer K.L., Gilbert J.R., Agarwal A., Postel E.A., Haines J.L., and Pericak-Vance M.A. Independent effects of complement factor H Y402H polymorphism and cigarette smoking on risk of age-related macular degeneration. Ophthalmology 114 (2007) 1151-1156
193. Dandekar S.S., Jenkins S.A., Peto T., Bird A.C., and Webster A.R. Does smoking influence the type of age related macular degeneration causing visual impairment?. Br. J. Ophthalmol. 90 (2006) 724-727
194. Klein R., Knudtson M.D., Cruickshanks K.J., and Klein B.E. Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration: the Beaver Dam Eye Study. Arch. Ophthalmol. 126 (2008) 115-121
195. Chow C.K., Thacker R.R., Changchit C., Bridges R.B., Rehm S.R., Humble J., and Turbek J. Lower levels of vitamin C and carotenes in plasma cigarette smokers. J. Am. Coll. Nutr. 5 (1986) 305-312
196. Church D.F., and Pryor W.A. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ. Health Perspect. 64 (1985) 111-126
197. Despriet D.D., Klaver C.C., Witteman J.C., Bergen A.A., Kardys I., de Maat M.P., Boekhoorn S.S., Vingerling J.R., Hofman A., Oostra B.A., Uitterlinden A.G., Stijnen T., van Duijn C.M., and de Jong P.T. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 296 (2006) 301-309
198. Sepp T., Khan J.C., Thurlby D.A., Shahid H., Clayton D.G., Moore A.T., Bird A.C., and Yates J.R. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest. Ophthalmol. Vis. Sci. 47 (2006) 536-540
199. DeAngelis M.M., Ji F., Kim I.K., Adams S., Capone Jr. A., Ott J., Miller J.W., and Dryja T.P. Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration. Arch. Ophthalmol. 125 (2007) 49-54
200. Craig W.Y., Palomaki G.E., and Haddow J.E. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 298 (1989) 784-788
201. Kanda A., Abecasis G., and Swaroop A. Inflammation in the pathogenesis of age-related macular degeneration. Br. J. Ophthalmol. 92 (2008) 448-450
202. Gold B., Merriam J.E., Zernant J., Hancox L.S., and Taiber A.J. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 38 (2006) 458-462
203. Maller J., George S., Purcell S., Fagerness J., Altshuler D., Daly M.J., and Seddon J.M. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat. Genet. 38 (2006) 1055-1059
204. Rodríguez de Córdoba S., Esparza-Gordillo J., Goicoechea de Jorge E., Lopez-Trascasa M., and Sánchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol. Immunol. 41 (2004) 355-367
205. Wu Z., Lauer T.W., Sick A., Hachett S.F., and Campochiaro P.A. Oxidative stress modulates complement factor H expression in retinal pigmented epithelial cells by acetylation of FOXO3. J. Biol. Chem. 282 (2007) 22414-22425
206. Radeke M.J., Peterson K.E., Johnson L.V., and Anderson D.H. Disease susceptibility of the human macula: differential gene transcription in the retinal pigmented epithelium/choroid. Exp. Eye Res. 85 (2007) 366-380
207. Jha P., Bora P.S., and Bora N.S. The role of complement system in ocular diseases including uveitis and macular degeneration. Mol. Immunol. 44 (2007) 3901-3908
208. Espinosa-Heidmann D.G., Suner I.J., Catanuto P., Hernandez E.P., Marin-Castano M.E., and Cousins S.W. Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD. Invest. Ophthalmol. Vis. Sci. 47 (2006) 729-737
209. Decanini A., Nordgaard C.L., Feng X., Ferrington D.A., and Olsen T.W. Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration. Am. J. Ophthalmol. 143 (2007) 607-615
210. Choudhary S., Xiao T., Srivastava S., Zhang W., Chan L.L., Vergara L.A., Van Kuijk F.J., and Ansari N.H. Toxicity and detoxification of lipid-derived aldehydes in cultured retinal pigmented epithelial cells. Toxicol. Appl. Pharmacol. 204 (2005) 122-134
211. Khan J.C., Shahid H., Thurlby D.A., Bradley M., Clayton D.G., Moore A.T., Bird A.C., Yates J.R., and Genetic Factors in AMD Study. Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight. Br. J. Ophthalmol. 90 (2006) 29-32
212. Weiter J.J., Delori F.C., Wing G.L., and Fitch K.A. Relationship of senile macular degeneration to ocular pigmentation. Am. J. Ophthalmol. 99 (1985) 185-187
213. Hyman L.G., Lilienfeld A.M., Ferris F.L., and Fine S.L. Senile macular degeneration: a case-control study. Am. J. Epidemiol. 118 (1983) 213-227
214. Frank R.N., Puklin J.E., Stock C., and Canter L.A. Race, iris color, and age-related macular degeneration. Trans. Am. Ophthalmol. Soc. 98 (2000) 109-115
215. Benedek G.B. Theory of transparency of the eye. Appl. Opt. 10 (1971) 459-473
216. Shiels A., and Hejtmancik J.F. Genetic origins of cataract. Arch. Ophthalmol. 125 (2008) 165-173
217. Hejtmancik J.F., and Kantorow M. Molecular genetics of age-related cataract. Exp. Eye Res. 79 (2004) 3-9
218. McCarty C.A., and Taylor H.R. The genetics of cataract. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1677-1678
219. Leske M.C., Chylack Jr. L.T., Wu S.Y., and The Lens Opacities Case-Control Study. Risk factors for Cataract. Arch. Ophthalmol. 109 (1991) 244-251
220. Familial aggregation of lens opacities: the Framingham Eye Study and the Framingham Offspring Eye Study. Am. J. Epidemiol. 140 (1994) 555-564
221. The Italian-American Cataract Study Group. Incidence and progression of cortical, nuclear, and posterior subcapsular cataracts. Am. J. Ophthalmol. 118 (1994) 623-631
222. The Italian-American Cataract Study Group. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. Am. J. Epidemiol. 133 (1991) 541-553
223. Klein B.E., Klein R., Linton K.L., and The Beaver Dam Eye Study. Prevalence of age-related lens opacities in a population. Ophthalmology 99 (1992) 546-552
224. Delcourt C., Cristol J.P., Tessier F., Leger C.L., Descomps B., and Papoz L. Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Pathologies Oculaires Liees a l'Age. Am. J. Epidemiol. 151 (2000) 497-504
225. Younan C., Mitchell P., Cumming R.G., Panchapakesan J., Rochtchina E., Hales A.M., and The Blue Mountains Eye Study. Hormone replacement therapy, reproductive factors, and the incidence of cataract and cataract surgery. Am. J. Epidemiol. 155 (2002) 997-1006
226. Kelly S.P., Thornton J., Edwards R., Sahu A., and Harrison R. Smoking and cataract: review of causal association. J. Cataract Refract. Surg. 31 (2005) 2395-2404
227. Ejdervik Lindblad B., Håkansson N., Philipson B., Wolk A., and A prospective cohort study of women. Alcohol consumption and risk of cataract extraction. Ophthalmology 114 (2007) 680-685
228. Ritter L.L., Klein B.E., Klein R., and Mares-Perlman J.A. Alcohol use and lens opacities in the Beaver Dam Eye Study. Arch. Ophthalmol. 111 (1993) 113-117
229. Cumming R.G., and Mitchell P. Alcohol, smoking, and cataracts: the Blue Mountains Eye Study. Arch. Ophthalmol. 115 (1997) 1296-1303
230. Klein B.E., Klein R., Lee K.E., and Meuer S.M. Socioeconomic and lifestyle factors and the 10-year incidence of age-related cataracts. Am. J. Ophthalmol. 136 (2003) 506-512
231. Tsai S.Y., Hsu W.M., Cheng C.Y., Liu J.H., and Chou P. Epidemiologic study of age-related cataracts among an elderly Chinese population in Shih-Pai, Taiwan. Ophthalmology 110 (2003) 1089-1095
232. Taylor H.R., West S.K., Rosenthal F.S., Munoz B., Newland H.S., Abbey H., and Emmett E.A. Effect of ultraviolet radiation on cataract formation. N. Engl. J. Med. 319 (1988) 1429-1433
233. Bochow T.W., West S.K., Azar A., Munoz B., Sommer A., and Taylor H.R. Ultraviolet light exposure and risk of posterior subcapsular cataracts. Arch. Ophthalmol. 107 (1989) 369-372
234. Jonasson F., Arnarsson A., Sasaki H., and Sasaki K. Epidemiological support for damage from solar UV radiation to the eye in the Reykjavik Eye Study. Acta Ophthalmol. Scand. 82 (2004) 342
235. Pastor-Valero M., Fletcher A.E., de Stavola B.L., and Chaqués-Alepúz V. Years of sunlight exposure and cataract: a case-control study in a Mediterranean population. BMC Ophthalmol. 7 (2007) 18
236. Klein B.E., Klein R., and Lee K.E. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am. J. Ophthalmol. 126 (1998) 782-790
237. Tan J., Wang J.J., Flood V., Kaushik S., Barclay A., Brand-Miller J., and Mitchel P. Carbohydrate nutrition, glycemic index, and the 10-y incidence of cataract 1-3. Am. J. Clin. Nutr. 85 (2007) 1502-1508
238. Maritim A.C., Sanders R.A., and Watkins J.B. Diabetes, oxidative stress and antioxidant: a review. J. Biochem. Mol. Toxicol. 17 (2003) 24-38
239. Chiu C., and Taylor A. Nutritional antioxidants and age-related cataract and maculopathy. Exp. Eye Res. 84 (2007) 229-245
240. Babizhayev M.A. Accumulation of lipid peroxidation products in human cataracts. Acta Ophthalmol. 67 (1989) 281-287
241. Taylor A., Jacques P.F., and Epstein E.M. Relations among aging, antioxidant status, and cataract. Am. J. Clin. Nutr. 62 (1995) 1439-1447
242. Chatterjee A., Milton R.C., and Thyle S. Prevalence and aetiology of cataract in Punjab. Br. J. Ophthalmol. 66 (1982) 35-42
243. Wang G., Spector A., Luo C., and The Epidemiological Study Group. Prevalence of age-related cataract in Ganzi and Shanghai. Chin. Med. J. 103 (1990) 945-951
244. Whitfield R., Schwab L., Ross-Degnan D., Steinkuller P., and Swartwood J. Blindness and eye disease in Kenya: ocular status results from Kenya rural blindness prevention project. Br. J. Ophthalmol. 74 (1990) 333-340
245. Christen W.G., Liu S., Glynn R.J., Gaziano J.M., and Buring J.E. Dietary carotenoids, vitamins C and E, and risk of cataract in women. Arch. Ophthalmol. 126 (2008) 102-109
246. Tarwadi V.K., Chiplonkar S.A., and Agte V. Dietary and nutritional biomarkers of lens degeneration, oxidative stress and micronutrient inadequacies in Indian cataract patients. Clin. Nutr. (2008)
247. Mibu H., Nagata M., and Hikida M. A study on lipid peroxide-induced lens damage in vitro. Exp. Eye Res. 58 (1994) 85-90
248. Park J., and Floyd R.A. Lipid peroxidation products mediate the formation of 8-hydroxy-deoxyguanosine in DNA. Free Radic. Biol. Med. 12 (1992) 245-250
249. Odrich S., Merriam G.R., Medvedovsky C., and Worgul B.V. Micronucleation in the lens epithelium following in vivo exposure to physical and chemical mutagens. Lens Res. 5 (1988) 203-216
250. Spector A., Wang G., Wang R., Li W., and Kuszak J.R. A brief photochemically induced oxidative insult causes irreversible lens damage and cataract. I: Transparency and epithelial cell layer. Exp. Eye Res. 60 (1995) 471-481
251. Spector A., Wang G., Wang R., Li W., and Kleiman N.J. A brief photochemically induced oxidative insult causes irreversible lens damage and cataract. II: Mechanism of action. Exp. Eye Res. 60 (1995) 483-493
252. Sidjanin D., Zigman S., and Reddan J. DNA damage and repair in rabbit lens epithelial cells following UVA radiation. Curr. Eye Res. 12 (1993) 773-781
253. Kleiman N.J., Wang R.R., and Spector A. Hydrogen peroxide-induced DNA damage in bovine lens epithelial cells. Mutat. Res. 240 (1990) 35-45
254. Kleiman N.J., Wang R.R., and Spector A. Ultraviolet light induced DNA damage and repair in bovine lens epithelial cells. Curr. Eye Res. 9 (1990) 1185-1193
255. Reddy V.N., Kasahara E., Hiraoka M., Lin L.R., and Ho Y.S. Effects of variation in superoxide dismutases (SOD) on oxidative stress and apoptosis in lens epithelium. Exp. Eye Res. 79 (2004) 859-868
256. Matsui H., Lin L., Ho Y., and Reddy V.N. The effect of up- and downregulation of MnSOD enzyme on oxidative stress in human lens epithelial cells. Invest. Ophthal. Vis. Sci. 44 (2003) 3467-3475
257. Kleiman N.J., and Spector A. DNA single strand breaks in human lens epithelial cells from patients with cataract. Curr. Eye Res. 12 (1993) 423-431
258. Worgul B.V., David J., Odrich S., Merriam G.R., Medvedovsky C., Merriam J.C., Trokel S.L., and Geard C.R. Evidence of genotoxic damage in human cataractous lenses. Mutagenesis 6 (1991) 495-499
259. Unal M., Guven M., Batar B., Ozaydin A., Sarici A., and Devranoglu K. Polymorphism of DNA repair genes XPD and XRCC1 and risk of cataract development. Exp. Eye Res. 85 (2007) 328-334
260. Collins A.R., Duthie S.J., and Dobson V.L. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 14 (1993) 1733-1735
261. Singh N.P., McCoy M.T., Tice R.R., and Schneider L.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175 (1988) 184-191